RxDoctor Payments Data

Richard Nussbaum, MD

Orthopedic Surgery · Sherman Oaks, CANPI 1972528297

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $217,610 of the $238,399 with a category attached, or 91.3%. Surgalign Spine Technologies, Inc. accounts for 89.3% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $83,793 and has fallen 99.0% since, to $809 in 2025. Among orthopedic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$238,399in general payments, 2019–2025

Across 84 payments — averaging $2838.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Surgalign Spine Technologies, Inc.$213K
  • Xtant Medical Inc$16K
  • Precision Spine, Inc.$4K
  • Silony Medical Corp.$3K
  • Relievant Medsystems, Inc.$579
  • Kyocera Medical Technologies, Inc.$377
  • plus $1K from 9 others
$3,902in research payments, 2019–2025

Across 1 payment — averaging $3902.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Surgalign Spine Technologies, Inc.$4K

What the payments were for

  • Royalty or licence$217,61091%
  • Consulting fees$12,8295%
  • Travel & lodging$4,7552%
  • Food & beverage$3,2041%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$238,399 in reported general payments places this provider in the 95th percentile of 130 orthopedic surgery providers in California.

See all orthopedic surgery providers in California

Medicare billing

Part B allowed, 2024
$45,271
Medicare patients
112
Services billed
278

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen15$156
Gabapentin14$146
Hydromorphone Hcl19$116

Paid to pharmacies, not to this prescriber.

Other orthopedic surgery in Sherman Oaks

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →